Goldman, Sachs

Goldman Sachs Upgrades Hewlett Packard Enterprise, Citing Strategic Shift

14.01.2026 - 19:22:04 | boerse-global.de

Hewlett Packard Enterprise US42824C1099

Goldman Sachs Upgrades Hewlett Packard Enterprise, Citing Strategic Shift - Foto: über boerse-global.de

Goldman Sachs has issued a bullish upgrade for Hewlett Packard Enterprise (HPE), shifting its rating to "Buy" and raising its price target to $31.00 from $28.00. The investment bank's optimism centers on HPE's transformative acquisition of Juniper Networks and the resulting strategic pivot toward a more networking-centric business model.

The core of Goldman's upgraded assessment lies in a revised financial projection. Analysts now forecast that the networking segment will contribute approximately 50% of the company's operating income (EBIT) by fiscal year 2026. On a pro forma basis, they project roughly 6% revenue growth for the period spanning 2025 to 2028. This growth is expected to be accompanied by an expansion of operating margins by more than 250 basis points, driven by the altered portfolio mix, and mid-single-digit compound annual growth in earnings per share (EPS).

Institutional Positioning Reflects Diverging Views

Recent regulatory filings reveal a mixed picture of institutional sentiment. While overall ownership remains concentrated, with institutions and hedge funds holding about 80.78% of shares, individual moves varied significantly last quarter. Nordea Investment Management reduced its stake by 9.7%, selling 772,819 shares, to hold a remaining position of 7,172,952 shares valued at approximately $173.3 million.

Conversely, other major investors substantially increased their exposure. Empowered Funds boosted its holdings by 317.3%, adding 113,906 shares, and the Czech National Bank raised its position by 6.4%, acquiring an additional 19,415 shares. These contrasting actions suggest some investors are taking profits while others are building positions aligned with the networking and artificial intelligence growth narrative.

Recent Performance and Forward Guidance

HPE's latest quarterly report (Q4 FY2025) presented a blend of challenges and strengths. Revenue of $9.7 billion fell short of the consensus estimate of $9.91 billion. Management attributed this primarily to delays in AI server orders related to government-sponsored AI initiatives. However, adjusted earnings per share of $0.62 surpassed analyst expectations of $0.59.

Should investors sell immediately? Or is it worth buying Hewlett Packard Enterprise?

Looking ahead, the company's guidance for fiscal year 2026 sets an EPS target range of $2.25 to $2.45. For the first quarter, HPE anticipates EPS between $0.57 and $0.61. In a separate capital allocation move, the board has increased the quarterly dividend, which now annualizes to $0.57 per share, offering a yield of around 2.6%. The next payment is scheduled for January 16.

Product Strategy Underpins the Thesis

Recent product launches support Goldman's positive thesis. At the NRF 2026 conference, HPE showcased new retail and AI infrastructure solutions, featuring autonomous capabilities within its Aruba switches and AI-native retail analytics platforms. A key strategic initiative is the integration of Juniper's Mist AI technology into the Aruba portfolio, which is designed to simplify operations and solidify networking as a higher-growth, higher-margin pillar for the business.

Key Risks and Market Context

The realization of Goldman's upbeat forecast hinges on two critical conditions. First, HPE must successfully integrate Juniper and achieve the projected margin improvements from the new portfolio mix. Second, a normalization in the timing of AI server orders is required. Fulfillment of both would support the upward trajectory, while further delays or integration issues could moderate the recovery.

In current market trading, HPE shares are priced at $22.29. The broader analyst consensus remains more cautious, with a "Hold" rating and an average price target of $25.53, notably below Goldman Sachs's $31.00 target.

Ad

Hewlett Packard Enterprise Stock: Buy or Sell?! New Hewlett Packard Enterprise Analysis from January 14 delivers the answer:

The latest Hewlett Packard Enterprise figures speak for themselves: Urgent action needed for Hewlett Packard Enterprise investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from January 14.

Hewlett Packard Enterprise: Buy or sell? Read more here...

So schätzen die Börsenprofis Goldman Aktien ein!

<b>So schätzen die Börsenprofis Goldman Aktien ein!</b>
Seit 2005 liefert der Börsenbrief trading-notes verlässliche Anlage-Empfehlungen – dreimal pro Woche, direkt ins Postfach. 100% kostenlos. 100% Expertenwissen. Trage einfach deine E-Mail Adresse ein und verpasse ab heute keine Top-Chance mehr. Jetzt abonnieren.
Für. Immer. Kostenlos.
US42824C1099 | GOLDMAN | boerse | 68486725 |

Weitere Meldungen

ANALYSE-FLASH: Goldman senkt Ziel für Henkel auf 70 Euro - 'Sell' Die US-Investmentbank Goldman Sachs hat das Kursziel für Henkel DE0006048432 vor Quartalszahlen von 73 auf 70 Euro gesenkt und die Einstufung auf "Sell" belassen. (Boerse, 02.04.2026 - 12:35) weiterlesen...

ANALYSE-FLASH: Goldman hebt Ziel für Evonik auf 20 Euro - 'Buy' Die US-Investmentbank Goldman Sachs hat das Kursziel für Evonik DE000EVNK013 vor Quartalszahlen von 18 auf 20 Euro angehoben und die Einstufung auf "Buy" belassen. (Boerse, 02.04.2026 - 11:20) weiterlesen...

ANALYSE-FLASH: Goldman hebt Rheinmetall auf 'European Conviction List' - 'Buy' Die US-Investmentbank Goldman Sachs hat die Rheinmetall-Aktie DE0007030009 in die "European Conviction List" für besonders aussichtsreiche Werte aufgenommen. (Boerse, 01.04.2026 - 19:05) weiterlesen...

AKTIE IM FOKUS: Goldman Sachs treibt kräftige Rheinmetall-Erholung voran Die Aktie von Rheinmetall DE0007030009 hat sich am Mittwoch im freundlichen Gesamtmarkt weiter von ihrem am Montag erreichten Elf-Monats-Tief nach oben hin abgesetzt. (Boerse, 01.04.2026 - 16:51) weiterlesen...

ANALYSE-FLASH: Goldman senkt Ziel für Lanxess auf 21 Euro - 'Neutral' Die US-Investmentbank Goldman Sachs hat das Kursziel für Lanxess DE0005470405 vor Zahlen zum ersten Quartal von 23 auf 21 Euro gesenkt und die Einstufung auf "Neutral" belassen. (Boerse, 01.04.2026 - 12:34) weiterlesen...

ANALYSE-FLASH: Goldman hebt Sartorius Stedim Biotech auf 'Buy' - Ziel gesenkt Die US-Investmentbank Goldman Sachs hat das Kursziel für Sartorius Stedim FR0013154002 von 235 auf 214 Euro gesenkt, die Aktien aber von "Neutral" auf "Buy" hochgestuft. (Boerse, 30.03.2026 - 09:04) weiterlesen...